Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

393
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
393
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Introduction to Hemostasis01:05

Introduction to Hemostasis

15.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.0K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Potential of Calebin-A in Targeting Obesity-Related Genes and Pathways.

Journal of cellular and molecular medicine·2026
Same author

Superoxide Dismutase-Centered Modulation by Curcumin in Cardiovascular Diseases: Mechanistic Insights and Translational Implications.

Journal of cellular and molecular medicine·2026
Same author

Effects of trehalose supplementation on bone healing, physical function, and pain in patients with pertrochanteric fractures: a randomized controlled trial.

Scientific reports·2026
Same author

Identification of Genetic Determinants of Weight Loss Efficacy After Roux-en-Y Gastric Bypass Surgery.

Bariatric surgical practice and patient care·2026
Same author

Promising Anti-Cancer Effects and Mechanisms of Baicalin and Baicalein in the Treatment of Oral Cancer: A Comprehensive Review.

Oral diseases·2026
Same author

Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Endocrinology, diabetes & metabolism·2026

Related Experiment Video

Updated: Feb 20, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.3K

Curcumin, hemostasis, thrombosis, and coagulation.

Faeze Keihanian1,2, Amin Saeidinia3, Ramin Khameneh Bagheri2

  • 1Pharmaceutical Research Division, Booali Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Journal of Cellular Physiology
|October 21, 2017
PubMed
Summary

Curcumin, derived from turmeric, shows significant potential in managing cardiovascular disease by positively impacting blood clotting and platelet function. This review highlights its antithrombotic and anticoagulant properties for potential therapeutic use.

Keywords:
Curcuma longaCurcuminanticoagulant agentantithrombotic agentshemostasis

More Related Videos

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.2K
Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
09:50

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin

Published on: December 22, 2023

2.4K

Related Experiment Videos

Last Updated: Feb 20, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.3K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.2K
Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
09:50

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin

Published on: December 22, 2023

2.4K

Area of Science:

  • Pharmacology and Herbal Medicine
  • Cardiovascular Research
  • Hemostasis and Thrombosis

Background:

  • Atherothrombotic cardiovascular disease is a leading global cause of mortality.
  • Platelet activation and aggregation are critical in hemostasis and thrombosis.
  • Herbal medicines offer potential in managing cardiovascular disease progression, affecting coagulation and platelet function.

Purpose of the Study:

  • To review existing literature on curcumin's effects on hemostasis, anticoagulation, and fibrinolysis.
  • To explore the molecular mechanisms behind curcumin's antiplatelet and anticoagulant activities.
  • To discuss the implications of curcumin for cardiovascular disease treatment.

Main Methods:

  • Comprehensive literature review of studies on curcumin and its effects on hemostasis and thrombosis.
  • Analysis of molecular mechanisms underlying curcumin's antithrombotic properties.
  • Synthesis of findings regarding curcumin's therapeutic potential in cardiovascular disease.

Main Results:

  • Curcumin exhibits positive activity in hemostasis, anticoagulation, and fibrinolysis.
  • Scientific evidence supports curcumin's anti-inflammatory, antioxidant, and cardiovascular protective effects.
  • Molecular mechanisms confirm curcumin's antiplatelet and anticoagulant capabilities.

Conclusions:

  • Curcumin demonstrates significant potential as a therapeutic agent for cardiovascular disease.
  • Its demonstrated effects on blood clotting and platelet function warrant further investigation.
  • Curcumin represents a promising natural compound for complementary and alternative medicine in cardiovascular health.